Roberta Grande

676 total citations
16 papers, 135 citations indexed

About

Roberta Grande is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roberta Grande has authored 16 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Roberta Grande's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (6 papers). Roberta Grande is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (6 papers). Roberta Grande collaborates with scholars based in Italy and Canada. Roberta Grande's co-authors include Teresa Gamucci, Isabella Sperduti, Giovanni Mansueto, Enzo Maria Ruggeri, Filomena Narducci, Enrico Cortesi, G. Zampa, Lucia Mentuccia, Domenico Corsi and Silvia Quadrini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Frontiers in Oncology.

In The Last Decade

Roberta Grande

15 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Grande Italy 8 83 53 25 22 22 16 135
Antonio Franco Italy 9 46 0.6× 159 3.0× 10 0.4× 5 0.2× 89 4.0× 33 223
Q. Molenaar Netherlands 6 38 0.5× 67 1.3× 39 1.6× 3 0.1× 6 0.3× 14 115
Salvatore Barbaro Italy 6 134 1.6× 108 2.0× 21 0.8× 14 0.6× 3 0.1× 9 163
Ana Ávila Bernabéu Spain 6 15 0.2× 27 0.5× 6 0.2× 29 1.3× 20 0.9× 10 103
M Rubbini Italy 6 66 0.8× 68 1.3× 8 0.3× 2 0.1× 18 0.8× 18 114
Maren Darsow Germany 4 124 1.5× 110 2.1× 10 0.5× 51 2.3× 7 212
Marinde J. G. Bond Netherlands 5 41 0.5× 52 1.0× 13 0.5× 4 0.2× 11 0.5× 10 90
Ross M. Beckman United States 8 135 1.6× 104 2.0× 3 0.1× 12 0.5× 14 0.6× 12 181
Marcel Cazemier Netherlands 8 37 0.4× 177 3.3× 13 0.5× 6 0.3× 11 0.5× 8 250
Nick Wadd United Kingdom 5 45 0.5× 28 0.5× 6 0.2× 5 0.2× 16 0.7× 10 83

Countries citing papers authored by Roberta Grande

Since Specialization
Citations

This map shows the geographic impact of Roberta Grande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Grande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Grande more than expected).

Fields of papers citing papers by Roberta Grande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Grande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Grande. The network helps show where Roberta Grande may publish in the future.

Co-authorship network of co-authors of Roberta Grande

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Grande. A scholar is included among the top collaborators of Roberta Grande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Grande. Roberta Grande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Signorelli, Carlo, Roberta Grande, Salvatore De Marco, et al.. (2021). Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience. Anticancer Research. 41(5). 2553–2561. 1 indexed citations
3.
Moretto, Roberto, Daniele Rossini, Sara Lonardi, et al.. (2020). Oligometastatic colorectal cancer: Prognostic implications of tumor load, role of locoregional treatments, and of first-line therapy intensification—A pooled analysis of TRIBE and TRIBE2 studies by GONO.. Journal of Clinical Oncology. 38(4_suppl). 12–12. 3 indexed citations
4.
Cremolini, Chiara, Carlotta Antoniotti, Sara Lonardi, et al.. (2019). Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the first- and second-line treatment of unresectable mCRC.. Journal of Clinical Oncology. 37(15_suppl). 3508–3508. 14 indexed citations
5.
Grande, Roberta, Clara Natoli, Ida Pavese, et al.. (2016). Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis. PLoS ONE. 11(7). e0157751–e0157751. 14 indexed citations
6.
Antoniotti, Carlotta, Chiara Cremolini, Fotios Loupakis, et al.. (2016). Modified FOLFOXIRI (mFOLFOXIRI) plus cetuximab (cet), followed by cet or bevacizumab (bev) maintenance, in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): Results of the phase II randomized MACBETH trial by GONO.. Journal of Clinical Oncology. 34(15_suppl). 3543–3543. 8 indexed citations
7.
Grande, Roberta, Carlo Garufi, Ida Pavese, et al.. (2014). Treatment (T) of metastatic colorectal cancer (mCRC) patients (pts) ≥75 years (y) old in clinical practice: A multicenter analysis.. Journal of Clinical Oncology. 32(15_suppl). e14514–e14514. 2 indexed citations
8.
Cremolini, Chiara, Fotios Loupakis, Lisa Salvatore, et al.. (2014). Modified FOLFOXIRI plus cetuximab (cet) as induction treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Preliminary results of the phase II randomized Macbeth trial by GONO group.. Journal of Clinical Oncology. 32(15_suppl). 3596–3596. 5 indexed citations
9.
Grande, Roberta, Isabella Sperduti, Alain Gelibter, et al.. (2013). Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?. SpringerPlus. 2(1). 185–185. 1 indexed citations
10.
Grande, Roberta, Domenico Corsi, Raffaello Mancini, et al.. (2013). Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis. PLoS ONE. 8(12). e80188–e80188. 8 indexed citations
11.
Grande, Roberta, Filomena Narducci, Giovanni Mansueto, et al.. (2013). Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study. Supportive Care in Cancer. 21(6). 1691–1695. 13 indexed citations
12.
Moscetti, Luca, Fabrizio Nelli, Agnese Fabbri, et al.. (2013). Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study. Investigational New Drugs. 31(4). 1035–1043. 12 indexed citations
13.
Grande, Roberta, Maurizio Cosimelli, Domenico Corsi, et al.. (2012). Evaluation of relapse-free survival in T3N0 colon cancer: The role of chemotherapy—A multicentric retrospective analysis.. Journal of Clinical Oncology. 30(15_suppl). e14082–e14082. 1 indexed citations
14.
Grande, Roberta, Maurizio Cosimelli, Domenico Corsi, et al.. (2012). Evaluation of relapse-free survival in T3N0 colon cancer: The role of chemotherapy—A multicentric retrospective analysis.. Journal of Clinical Oncology. 30(4_suppl). 578–578. 1 indexed citations
15.
Narducci, Filomena, Roberta Grande, Lucia Mentuccia, et al.. (2011). Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study. Supportive Care in Cancer. 20(6). 1221–1226. 18 indexed citations
16.
Longo, Flavia, Giovanni Mansueto, Rita De Sanctis, et al.. (2010). Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy. Supportive Care in Cancer. 19(8). 1159–1164. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Franco Breakdown of academic impact, for papers by Q. Molenaar Breakdown of academic impact, for papers by Salvatore Barbaro Breakdown of academic impact, for papers by Ana Ávila Bernabéu Breakdown of academic impact, for papers by M Rubbini Breakdown of academic impact, for papers by Maren Darsow Breakdown of academic impact, for papers by Marinde J. G. Bond Breakdown of academic impact, for papers by Ross M. Beckman Breakdown of academic impact, for papers by Marcel Cazemier Breakdown of academic impact, for papers by Nick Wadd
Rankless by CCL
2026